Rambus Inc.

Fundamentals8.0
Price Action5.0
News Sentiment5.0
AI Rating
7.0

Key Drivers

  • High margins
  • Strong FCF
  • Significant intangibles

AI
AI Summary

7.0

Rambus's shift from pure IP licensing to a product-plus-royalty hybrid materially boosts cash-generation and margin durability but is already priced for near‑perfect execution, making the stock binary — strong upside if HBM4E/DDR5 ramps and royalty growth continue, sharp downside if they falter. Actionable: watch sequential revenue/FCF guidance and HBM4E/DDR5 adoption milestones alongside legal/governance developments as triggers for staging entries or cutting exposure.

Execution
Legal
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

8.0

Key Financial Insights:

  • High margins
  • Strong FCF
  • Significant intangibles

RMBS delivers exceptional margins, strong free cash flow and very low leverage, but is priced richly and carries significant intangible/investment exposure that tempers upside. #high-margin​ #rich-valuation‌

Price Behavior

5.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Downward trend
  • Below average
  • Rebounds present

RMBS has trended down over the last month from a short-term peak near $102.64 to $91.70, trading below the last-month average (~$94.2) and showing short-term bearish momentum despite sharp rebounds into the low $90s.

bearish
watchlist
Support Level: $87.6–$88.1
Resistance Level: $94–$99 (decisive > $100)

Wide swing from $102.64 to $87.59 (~15–17% range) indicating elevated volatility

Sentiment & News

5.0

Key News Insights:

  • Investor litigation
  • HBM4E launch
  • Institutional sell-off

Rambus faces escalating investor litigation and an institutional sell-down even as it advances HBM4E memory IP and maintains investor outreach.

LegalRisk
ProductProgress

Continued legal scrutiny and a reduced institutional stake increase near-term downside risk for RMBS despite product momentum that could support longer-term value